The statement addresses a public issue related to the FDA's decision-making process and potential biases in the approval of medical treatments. It also references a public figure and links to an external website for further information.
- The statement does not appear to cause harm directly but implies potential bias in a regulatory body, which could be seen as harmful if not substantiated. [-1]Principle 1:I will strive to do no harm with my words and actions.
- The statement does not engage in cyberbullying, harassment, or hate speech. It respects the privacy and dignity of others. [+1]Principle 2:I will respect the privacy and dignity of others and will not engage in cyberbullying, harassment, or hate speech.
- The statement does not explicitly promote understanding, empathy, or compassion. It is more critical in nature.Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- The statement engages in criticism of the FDA but does not engage in personal attacks or ad hominem arguments. [+1]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.
- The statement uses influence to highlight a potential issue in regulatory practices, which could be seen as aiming for societal betterment. [+1]Principle 6:I will use my influence for the betterment of society.
- The statement upholds free speech and uses the platform to raise a public concern responsibly. [+1]Principle 7:I will uphold the principles of free speech and use my platform responsibly and with integrity.